Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Immune checkpoint inhibitors: a promising anticancer therapy
HTML
Details
Locations
Year:
2019
Type:
review
Source:
Drug Discovery Today
DOI:
10.1016/j.drudis.2019.11.003
Authors:
Sima Singh,
Daniel Hassan,
Hibah M. Aldawsari,
Nagashekhara Molugulu,
Rahul Shukla,
Prashant Kesharwani
show all 6
Institutions:
University of KwaZulu-Natal,
King Abdulaziz University,
Monash University Malaysia,
Monash University,
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research,
Jamia Hamdard
show all 7
Language:
English
Topic:
Cancer Immunotherapy and Biomarkers
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
immune checkpoint inhibitors,
cancer immunotherapy,
immune-related adverse events,
treatment resistance,
predictive biomarkers,
combination therapy,
treatment duration
show all 7
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2984538501
FWCI:
2.244
Cites:
62
Cited by:
206
Related to:
10